Areas of Clinical and Research Interest

Dr. Christos Venetis is a distinguished clinician and researcher in the field of assisted reproduction. His areas of special clinical and research interest include recurrent implantation failure, poor ovarian response, and highly complex infertility cases.

His extensive experience and expertise in these areas have contributed significantly to understanding and effectively managing these challenges, helping many couples conceive without resorting to high-cost interventions of questionable effectiveness and safety.

Dr. Venetis’s expertise in these areas is reflected in his scientific work (peer-reviewed publications and invited lectures).

Books

Co-editor of a book on recurrent implantation failure examining research evidence on the effectiveness and safety of various proposed interventions. This book aims to help fertility specialists make optimal treatment decisions for their patients with RIF.
“Adjuvants in poor responders” by Christos Venetis, in Textbook of ART, 6th Ed. Vol 2, CRC Press, 2024

Selected Publications in Peer-Reviewed Journals

Iakovidou MC, Kolibianakis E, Zepiridis L, Venetis C. The role of endometrial scratching prior to in vitro fertilization: an updated systematic review and meta-analysis. Reprod Biol Endocrinol. 2023;21(1):89.
Venetis CA. Endometrial injury before IVF: light at the end of the tunnel or false hope? Hum Reprod. 2021;36(1):1-2.
Vermey BG, Chua SJ, Zafarmand MH, Wang R, Longobardi S, Cottell E, et al. Is there an association between oocyte number and embryo quality? A systematic review and meta-analysis. Reprod Biomed Online. 2019;39(5):751-63.
Venetis CA, Tilia L, Panlilio E, Kan A. Is more better? A higher oocyte yield is independently associated with more day-3 euploid embryos after ICSI. Hum Reprod. 2019;34(1):79-83.
Lensen S, Venetis C, Ng EHY, Young SL, Vitagliano A, Macklon NS, et al. Should we stop offering endometrial scratching prior to in vitro fertilization? Fertil Steril. 2019;111(6):1094-101.
Law YJ, Zhang N, Venetis CA, Chambers GM, Harris K. The number of oocytes associated with maximum cumulative live birth rates per aspiration depends on female age: a population study of 221 221 treatment cycles. Hum Reprod. 2019;34(9):1778-87.
Bosdou JK, Venetis CA, Dafopoulos K, Zepiridis L, Chatzimeletiou K, Anifandis G, et al. Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial. Hum Reprod. 2016;31(5):977-85.
Lainas TG, Sfontouris IA, Venetis CA, Lainas GT, Zorzovilis IZ, Tarlatzis BC, et al. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders. Hum Reprod. 2015;30(10):2321-30.
Kolibianakis EM, Venetis CA, Bosdou JK, Zepiridis L, Chatzimeletiou K, Makedos A, et al. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial. Hum Reprod. 2015;30(2):432-40.
Venetis CA, Papadopoulos SP, Campo R, Gordts S, Tarlatzis BC, Grimbizis GF. Clinical implications of congenital uterine anomalies: a meta-analysis of comparative studies. Reprod Biomed Online. 2014;29(6):665-83.
Venetis CA. The Bologna criteria for poor ovarian response: the good, the bad and the way forward. Hum Reprod. 2014;29(9):1839-41.
Bosdou JK, Venetis CA, Kolibianakis EM, Toulis KA, Goulis DG, Zepiridis L, et al. The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(2):127-45.
Kolibianakis EM, Venetis CA, Tarlatzis BC. DHEA administration in poor responders. Hum Reprod. 2011;26(3):730-1; author reply 1.
Venetis CA, Kolibianakis EM, Tarlatzi TB, Tarlatzis BC. Evidence-based management of poor ovarian response. Ann N Y Acad Sci. 2010;1205:199-206.
Venetis CA, Kolibianakis EM, Tarlatzi TB, Tarlatzis BC. Benefits of luteinizing hormone activity in ovarian stimulation for IVF. Reprod Biomed Online. 2009;18 Suppl 2:31-6.
Toulis KA, Goulis DG, Venetis CA, Kolibianakis EM, Tarlatzis BC, Papadimas I. Thyroid autoimmunity and miscarriages: the corpus luteum hypothesis. Med Hypotheses. 2009;73(6):1060-2.
Kyrou D, Kolibianakis EM, Venetis CA, Papanikolaou EG, Bontis J, Tarlatzis BC. How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril. 2009;91(3):749-66.
Kolibianakis EM, Venetis CA, Diedrich K, Tarlatzis BC, Griesinger G. Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update. 2009;15(6):613-22.

Selected Invited Lectures

Lecture on “Recurrent Implantation Failure and the role of PGD” delivered at the LIFE Symposium, Merck Thailand, Bangkok, Thailand, June 2017.
Lecture on “Recurrent Implantation Failure: Role of progesterone” delivered at a scientific meeting organized by Fertility SA, Adelaide, Australia, May 2018.
Lecture on “Poor ovarian response: what stimulation” delivered at a scientific meeting organized by Fertility SA, Adelaide, Australia, May 2018.
Lecture on “Adjuvant in IVF: Any hope for poor responders?” delivered at the MSD APAC Stand Alone Scientific Symposium, Sydney, Australia, September 2018.
Lecture on “Evidence for the use of Melatonin, CoQ10 and other agents in poor ovarian response” delivered at the 8th ASPIRE Masterclass (Asia Pacific Initiative on Reproduction), Tokyo, Japan, January 2020.
Lecture (virtual) on “What is the role of endometrium in recurrent implantation failure?” delivered at the virtual seminar “The Endometrium in ART: Truths and Fallacies of the black box of embryo implantation” organized by the European Society of Human Reproduction and Embryology (ESHRE), October 2020.
Lecture (virtual) on “The role of the endometrium in recurrent implantation failure: Interventions to increase the probability of achieving pregnancy” delivered at the Panhellenic Fertility and Sterility Conference, May 2021.
Lecture (virtual) on “Adjuvant technologies and IVF” delivered at the “2nd Online Congress on Future Innovations for Embryologists,” June 2021.
Lecture (virtual) on “Dissociation of follicular endometrial events: To freeze or not to freeze?” delivered at the pre-conference seminar “MEFS exchange course: Recurrent implantation failure: Which treatment strategies improve ART outcome? – part 1” at the Virtual Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), June 2021.
Lecture on “Recurrent Implantation Failure and Reduced Ovarian Reserve” delivered at All About Fertility, Virtual Expo 2021, Australia, June 2021.
Lecture on “Advances in Endometrial Receptivity: How can we tackle the problem of recurrent implantation failure?” delivered at a scientific seminar at the Reproductive & Genetic Hospital of CITIC-Xiangya, China, July 2021.
Lecture on “Evidence based management of recurrent implantation failure” delivered at a scientific seminar at Shandong University Hospital, China, November 2021.
Lecture on “Recurrent implantation failure” delivered at a scientific seminar at Tianjin Medical University Hospital, China, November 2021.
Lecture on “Recurrent implantation failure: towards evidence-based management” delivered at a scientific seminar organized by Ferring Australia, March 2022.
Lecture on “Recurrent Implantation Failure: from an elusive entity to a standardized definition” delivered at a pre-congress seminar of the World Congress of the International Federation of Fertility Societies (IFFS), Athens, Greece, September 2023.
Lecture on “Recurrent Implantation Failure: what we know and what we don’t” delivered at the AcadeMe Fertility LATAM Congress, Mexico City, Mexico, May 2024.